We are live on
!
Find out more
GHCM
Glen Harbor Capital Management Portfolio holdings
AUM
$4.82B
1-Year Est. Return
4.69%
This Fund
S&P 500
This Quarter
Est. Return
+2.39%
1 Year Est. Return
+4.69%
3 Year Est. Return
+49.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.1B
AUM Growth
+$90.3M
(+2.3%)
Cap. Flow
+$24.5M
Cap. Flow
% of AUM
0.6%
Top 10 Holdings %
Top 10 Hldgs %
23.54%
Holding
1,292
New
24
Increased
788
Reduced
342
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$13.4M |
| 2 |
O'Reilly Automotive
ORLY
|
+$11.6M |
| 3 |
Affiliated Managers Group
AMG
|
+$11.5M |
| 4 |
Prudential Financial
PRU
|
+$11.2M |
| 5 |
Boeing
BA
|
+$7.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$13.4M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$12.3M |
| 3 |
American International
AIG
|
+$12.3M |
| 4 |
Aflac
AFL
|
+$9.5M |
| 5 |
Gilead Sciences
GILD
|
+$7.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.65% |
| 2 | Healthcare | 14.84% |
| 3 | Technology | 14.51% |
| 4 | Industrials | 11.84% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Parker-Hannifin
PH
$124B
| $6.62M | 0.16% |
41,446
-22,304
| -35% | -$3.53M |
|
|
AET
127
DELISTED
Aetna Inc
AET
| $6.55M | 0.16% |
43,146
-24,480
| -36% | -$3.46M |
|
|
DISCK
128
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $6.54M | 0.16% |
259,556
+46,818
| +22% | +$1.24M |
|
129
NVIDIA
NVDA
$4.84T
| $6.52M | 0.16% |
1,804,880
+14,080
| +0.8% | +$44.7K |
|
130
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15B
| $6.41M | 0.16% |
116,624
+62,816
| +117% | +$3.49M |
|
131
Boston Scientific
BSX
$72.4B
| $6.32M | 0.15% |
228,106
-124,746
| -35% | -$3.31M |
|
132
Northrop Grumman
NOC
$77.9B
| $6.25M | 0.15% |
24,352
-9,648
| -28% | -$2.41M |
|
133
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23B
| $6.2M | 0.15% |
138,336
+42,144
| +44% | +$1.89M |
|
134
Trane Technologies
TT
$101B
| $6.19M | 0.15% |
67,732
-420
| -0.6% | -$36.9K |
|
135
Centene
CNC
$30.6B
| $6.13M | 0.15% |
153,612
+52,224
| +52% | +$1.97M |
|
136
MarketAxess Holdings
MKTX
$5.71B
| $6.1M | 0.15% |
30,338
-6,160
| -17% | -$1.18M |
|
137
Packaging Corp of America
PKG
$22.1B
| $6.08M | 0.15% |
54,628
+20,048
| +58% | +$2.02M |
|
138
Healthpeak Properties
DOC
$15.1B
| $6.06M | 0.15% |
189,516
-10,846
| -5% | -$344K |
|
139
RB Global
RBA
$20.9B
| $6.03M | 0.15% |
209,808
-16,448
| -7% | -$510K |
|
140
Accenture
ACN
$104B
| $6.02M | 0.15% |
48,704
+19,568
| +67% | +$2.38M |
|
141
Welltower
WELL
$169B
| $6.02M | 0.15% |
80,376
-170
| -0.2% | -$12.4K |
|
142
Consolidated Edison
ED
$39.9B
| $6.01M | 0.15% |
74,392
+578
| +0.8% | +$46.7K |
|
143
Humana
HUM
$43.7B
| $5.94M | 0.15% |
24,668
+22,120
| +868% | +$5.01M |
|
144
Nordson
NDSN
$16.8B
| $5.92M | 0.14% |
48,790
-5,270
| -10% | -$644K |
|
145
Pfizer
PFE
$143B
| $5.77M | 0.14% |
181,018
+39,462
| +28% | +$1.24M |
|
146
Kroger
KR
$35.8B
| $5.71M | 0.14% |
244,834
+69,224
| +39% | +$1.96M |
|
147
Dorman Products
DORM
$3.91B
| $5.64M | 0.14% |
68,204
-17,476
| -20% | -$1.43M |
|
148
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
| $5.61M | 0.14% |
51,854
| – | – |
|
|
CA
149
DELISTED
CA, Inc.
CA
| $5.61M | 0.14% |
162,646
+32,648
| +25% | +$1.06M |
|
150
Trinity Industries
TRN
$2.53B
| $5.57M | 0.14% |
275,939
+64,211
| +30% | +$1.23M |
|
Similar funds
FIM
MCIM
EP
MIH
FCM
NA
TAM
TAM
Glen Harbor Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Glen Harbor Capital Management held 1,292 positions worth $4.1B, up 2.3% from $4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 3.5%. Glen Harbor Capital Management opened 24 new positions and exited 21, leaving the 1,292-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
- Glen Harbor Capital Management's largest Q2 2017 buy was Vistra: 93,522 shares worth $1.57M.
- Glen Harbor Capital Management added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $13.4M increase.
- Glen Harbor Capital Management's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $13.4M.
- Glen Harbor Capital Management fully exited Huntsman Corp in Q2 2017, selling an estimated $6.55M.
- Glen Harbor Capital Management's ten largest holdings make up 24% of its $4.1B portfolio in Q2 2017.
- Glen Harbor Capital Management opened 24 new positions and closed 21 in Q2 2017.
- Glen Harbor Capital Management's portfolio value rose 2.3% quarter-over-quarter to $4.1B.
Based on Glen Harbor Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.